Xenon Pharmaceuticals, Inc. (XENE)
59.70
+1.27
(+2.17%)
USD |
NASDAQ |
Apr 17, 16:00
59.70
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash from Investing (Quarterly) : 60.77M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | -36.89M |
| Oncolytics Biotech, Inc. | -0.0009M |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | -0.0539M |
| ProMIS Neurosciences, Inc. | -0.0007M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -79.03M |
| Cash from Financing (Quarterly) | 113.73M |
| Free Cash Flow | -280.51M |
| Free Cash Flow Per Share (Quarterly) | -0.9902 |
| Free Cash Flow to Equity (Quarterly) | -78.96M |
| Free Cash Flow to Firm (Quarterly) | -79.34M |
| Free Cash Flow Yield | -5.93% |